文献速递眼底病与葡萄膜炎

精炼疑似戊聚糖多硫酸钠视网膜病变患者的视网膜表型

REFINING THE RETINAL PHENOTYPE OF PATIENTS WITH SUSPECTED PENTOSAN POLYSULFATE SODIUM RETINOPATHY.
PubMed 文献 · Retina · 2023-01-01

本研究利用超广角成像和光学相干断层扫描,在大型学术中心回顾性分析104例有完整给药档案的患者的电子健康记录,以细化疑似戊聚糖多硫酸钠(PPS)毒性视网膜表型。26例(25%)被判定为PPS毒性;视网膜病变组平均暴露时长162.7个月、累积剂量1803.2 g,均高于无视网膜病变组的69.7个月、972.6 g(均P<0.001)。视网膜病变组黄斑外表型存在变异,4眼仅视盘周围受累,6眼向周边部延伸。

要点

  • 104例中26例(25%)被判定为PPS毒性视网膜病变。
  • 视网膜病变组平均暴露162.7个月、累积剂量1803.2 g,均高于无病变组(均P<0.001)。
  • 黄斑外表型存在变异:4眼仅视盘周围受累,6眼向周边部延伸。

核心结论

  • 长期暴露和较高累积剂量的PPS治疗所致视网膜毒性呈现表型变异。
  • 提供者在筛查患者时应关注毒性的黄斑外成分。
  • 了解不同视网膜表型可能防止继续暴露并降低威胁视力的黄斑受累疾病风险。

研究设计与样本

  • 利用大型学术中心电子健康记录识别有完整给药档案且具备超广角成像和光学相干断层扫描记录的患者。
  • 视网膜毒性初筛采用既往发表的影像学标准,分级采用既往报告的和新的分类系统。
  • 共纳入104例患者。

主要发现

  • 26例(25%)被判定为PPS毒性。
  • 视网膜病变组平均暴露时长162.7个月、累积剂量1803.2 g,无视网膜病变组分别为69.7个月、972.6 g(均P<0.001)。
  • 视网膜病变组黄斑外表型存在变异,4眼仅视盘周围受累,6眼向周边部延伸。

关键数值与推荐

  • 视网膜毒性初筛采用既往发表的影像学标准。
  • 分级采用既往报告的和新的分类系统。

临床怎么用

  • 提供者在筛查患者时应关注毒性的黄斑外成分。
  • 了解不同视网膜表型可能防止继续暴露并降低威胁视力的黄斑受累疾病风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To refine the retinal phenotypes of suspected pentosan polysulfate sodium toxicity using ultra-widefield imaging. METHODS: Patients with complete dosing profiles who visited the ophthalmology department and with ultra-widefield and optical coherence tomography imaging records were identified using electronic health records at a large academic center. Retinal toxicity was initially identified using previously published imaging criteria, while grading was categorized using both previously reported and new classification systems. RESULTS: One hundred and four patients were included in this study. Twenty-six (25%) were identified as having toxicity from PPS. The mean duration of exposure and cumulative dose between the retinopathy group (162.7 months, 1,803.2 g) were longer and higher compared with the nonretinopathy group (69.7 months, 972.6 g) (both P < 0.001). There was variability of extramacular phenotype in the retinopathy group, with four eyes having only peripapillary involvement and six eyes having far peripheral extension. CONCLUSION: Retinal toxicity in the setting of prolonged exposure and increased cumulative dosing from PPS therapy produces phenotypic variability. Providers should be aware of the extramacular component of toxicity when screening patients. Understanding the different retinal phenotypes may prevent continued exposure and reduce the risk of vision-threatening foveal-involving disease.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Kalaw FGP, Arias JD, Walker E, et al. REFINING THE RETINAL PHENOTYPE OF PATIENTS WITH SUSPECTED PENTOSAN POLYSULFATE SODIUM RETINOPATHY. Retina. 2023. PMID: 37229759. doi:10.1097/IAE.0000000000003844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。